M1C mediates LINE-1 transcription in PARP inhibitor-treated prostate cancer cells

Cancer Letters 2026

View at publisher
Authors: Keisuke Shigeta, Shinkichi Takamori, Hiroki Ozawa, Naoki Haratake, Mai Onishi, Tatsuaki Daimon, Tomohiro Kitano, Atrayee Bhattacharya, Atsushi Fushimi, Mototsugu Oya, Mark D. Long, Donald W. Kufe
DOI: 10.1016/j.canlet.2026.218320
Cited by: 1
References: 80

Fields of Study & Subjects

Chromosomal and Genetic Variations PARP inhibition in cancer therapy Telomeres Telomerase and Senescence

Publication details

Journal / source
Cancer Letters
Publisher
Elsevier BV
Volume
644
Pages
218320–218320
Publication date
12 February 2026
Language
EN